Evidence map›Paper›PMID 40330575›Full record

ArticleEuropean heart journal. Case reports2025

Pulmonary embolism with pulmonary hypertension or something far worse? Unveiling a rare and lethal pulmonary artery angiosarcoma: a case report.

Gianluca Guarnieri, Daniele Briguglia, Edoardo Conte, Daniele Andreini

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gianluca GuarnieriDepartment of Biomedical and Clinical Sciences, University of Milan, via Festa del Perdono, Milan 20122, Italy.ORCID https://orcid.org/0000-0003-0925-1618
Daniele BrigugliaDivision of University Cardiology, IRCCS Ospedale Galeazzi Sant'Ambrogio, via Belgioioso, Milan 20157, Italy.
Edoardo ConteDivision of University Cardiology, IRCCS Ospedale Galeazzi Sant'Ambrogio, via Belgioioso, Milan 20157, Italy.
Daniele AndreiniDepartment of Biomedical and Clinical Sciences, University of Milan, via Festa del Perdono, Milan 20122, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pulmonary artery angiosarcoma is a rare and highly malignant tumour. Its clinical presentation often mimics common pulmonary disorders such as pulmonary embolism or pneumonia, which frequently leads to misdiagnosis. Due to its aggressive nature and typical diagnostic delay, prognosis is generally poor, with survival often limited to a few months post-diagnosis. Case Summary: A 70-year-old female with a history of hypertension and no previous cardiac issues presented with progressive exertional dyspnoea unresponsive to anticoagulation after a diagnosis of pulmonary embolism. A chest computed tomography (CT) initially suggested a pulmonary embolism with an endoluminal filling defect in the right pulmonary artery. However, further investigation revealed a mass in the right pulmonary artery with a subsequent obliteration of the perihilar fat spaces, leading to a diagnosis of pulmonary artery angiosarcoma. Discussion: This case underscores the importance of considering pulmonary artery angiosarcoma in differential diagnoses for persistent pulmonary symptoms, especially when imaging and clinical signs are atypical for thromboembolic disease. Early recognition and a multidisciplinary approach are essential for improving outcomes in this rare but lethal malignancy, where prompt diagnosis may extend survival significantly.

Indexed as

Case reportPulmonary angiosarcomaPulmonary embolismPulmonary hypertension

Identifiers

PMID40330575
PMCPMC12055360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.